P&K Skin Research Center Co., Ltd.
Research P&K Skin Research Center Co., Ltd. (347740.KQ) on Bullrun: market cap KRW 43.76B, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker347740.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 43.76B
- Dividend yield3.3%
- Financial periodQ2 2026
- RevenueKRW 6.59B
- Net incomeKRW 1.53B
- Free cash flowKRW 1.93B
- Gross margin50.1%
Valuation Snapshot
latest market cap is KRW 43.76B; dividend yield is 3.3%.
Peer valuation comparison
Latest dividend yield is 3.3% versus a Healthcare sector median of 2.4% (37.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 43.76B | n/a | 3.3% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 KRW, yield 3.3%.
About P&K Skin Research Center Co., Ltd.
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is P&K Skin Research Center Co., Ltd.'s market cap?
P&K Skin Research Center Co., Ltd.'s market capitalization is KRW 43.76B.
Does P&K Skin Research Center Co., Ltd. pay a dividend?
P&K Skin Research Center Co., Ltd. has a dividend yield of 3.3%.
What does P&K Skin Research Center Co., Ltd. do?
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 2010 and is headquartered in Seoul, South Korea.